APA (7th ed.) Citation

NA, M., SM, B., S, I., DA, M., RMS, K., AF, E., & AA, H. (2026). Cerium oxide nanoparticles attenuate hepatic failure via blocking TGF-β/Smads and upregulating Nrf2/HO-1 signaling pathways in liver fibrosis rat model. Naunyn-Schmiedeberg's archives of pharmacology, 399(1), 745. https://doi.org/10.1007/s00210-025-04435-x

Chicago Style (17th ed.) Citation

NA, Mowaad, Baraka SM, Ibrahim S, Mansour DA, Korany RMS, El-Sayed AF, and Hassan AA. "Cerium Oxide Nanoparticles Attenuate Hepatic Failure via Blocking TGF-β/Smads and Upregulating Nrf2/HO-1 Signaling Pathways in Liver Fibrosis Rat Model." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 1 (2026): 745. https://doi.org/10.1007/s00210-025-04435-x.

MLA (9th ed.) Citation

NA, Mowaad, et al. "Cerium Oxide Nanoparticles Attenuate Hepatic Failure via Blocking TGF-β/Smads and Upregulating Nrf2/HO-1 Signaling Pathways in Liver Fibrosis Rat Model." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 1, 2026, p. 745, https://doi.org/10.1007/s00210-025-04435-x.